Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Cancer|November 15, 1981
Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancerT R Lininger, T R Fleming, R T Eagan
Seminars in Oncology|April 1, 1988
Surgical adjuvant therapy of rectal cancerM J O'Connell, L L Gunderson, T R Fleming
Investigational New Drugs|February 1, 1990
Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group studyC B Vaughn, S E Salmon, T R Fleming
Biometrics|December 1, 1995
Diagnostic plots to reveal functional form for covariates in multiplicative intensity modelsP M Grambsch, T M Therneau, T R Fleming
Controlled Clinical Trials|March 1, 1984
Considerations for monitoring and evaluating treatment effects in clinical trialsT R Fleming, S J Green, D P Harrington
Statistics in Medicine|July 15, 1997
Estimating the proportion of treatment effect explained by a surrogate markerD Y Lin, T R Fleming, V De Gruttola
Controlled Clinical Trials|December 1, 1984
Designs for group sequential testsT R Fleming, D P Harrington, P C O'Brien
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Policies for study monitoring and interim reporting of resultsS J Green, T R Fleming, J R O'Fallon
Cancer Treatment Reports|December 1, 1987
Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group StudyR Chapman, T R Fleming, J Van Damme, et al.
Statistics in Medicine|May 15, 1994
Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS researchT R Fleming, R L Prentice, M S Pepe, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Cancer|November 15, 1981
Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancerT R Lininger, T R Fleming, R T Eagan
Seminars in Oncology|April 1, 1988
Surgical adjuvant therapy of rectal cancerM J O'Connell, L L Gunderson, T R Fleming
Investigational New Drugs|February 1, 1990
Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group studyC B Vaughn, S E Salmon, T R Fleming
Biometrics|December 1, 1995
Diagnostic plots to reveal functional form for covariates in multiplicative intensity modelsP M Grambsch, T M Therneau, T R Fleming
Controlled Clinical Trials|March 1, 1984
Considerations for monitoring and evaluating treatment effects in clinical trialsT R Fleming, S J Green, D P Harrington
Statistics in Medicine|July 15, 1997
Estimating the proportion of treatment effect explained by a surrogate markerD Y Lin, T R Fleming, V De Gruttola
Controlled Clinical Trials|December 1, 1984
Designs for group sequential testsT R Fleming, D P Harrington, P C O'Brien
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Policies for study monitoring and interim reporting of resultsS J Green, T R Fleming, J R O'Fallon
Cancer Treatment Reports|December 1, 1987
Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group StudyR Chapman, T R Fleming, J Van Damme, et al.
Statistics in Medicine|May 15, 1994
Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS researchT R Fleming, R L Prentice, M S Pepe, et al.
Pageof 12